Adverse Effects and Comorbidities
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 190 Shown
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Contemporary Management of HIV: To Boost or Not to Boost: Advantages and Disadvantages of Boosted ART

    In this downloadable slideset, Eric S. Daar, MD, and Program Director Joseph J. Eron, Jr., MD, review advantages and disadvantages of boosted ART regimens for managing patients with HIV.
    Date Posted: 6/16/2017
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 1 comment / Last Comment: 6/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Adopting Lung Cancer Screening Recommendations for an HIV-Infected Individual With a Smoking History

    David A. Wohl MD - 5/31/2017
    What qualifies an HIV-infected past or current smoker for annual lung cancer screening using low-dose CT scans?
  • Contemporary Management of HIV: Best Practices for ART Management and Optimizing Outcomes in Persons of Color

    In this downloadable slideset, Lisa Hightow-Weidman, MD, MPH, and Program Director Eric S. Daar, MD, review key data and offer evidence-based guidance on linking and retaining persons of color in HIV care.
    Date Posted: 5/9/2017
  • Video Module cme-icon ce-icon

    Panel Discussion of Challenging Patient Cases in HIV

    Led by Kathleen E. Squires, MD, a panel of experts discusses their approach to management and prevention of HIV infection in complex clinical scenarios.
    Faculty: Joseph J. Eron, Jr. MD, Monica Gandhi MD, MPH, W. David Hardy MD, Kathleen E. Squires MD
    Released: 5/1/2017
  • Video Module cme-icon ce-icon

    Current Controversies in HIV Management

    Led by Joseph J. Eron, Jr., MD, a panel of experts discusses how they approach current controversies related to the management of patients with HIV infection.
    Faculty: Monica Gandhi MD, MPH, Joel E. Gallant MD, MPH, Kathleen E. Squires MD, Joseph J. Eron, Jr. MD, W. David Hardy MD, Kristen Marks MD
    Released: 5/1/2017
  • Learning Module cme-icon ce-icon

    CCO Independent Conference Coverage: Clinical Impact of New Data From CROI 2017

    In this Expert Analysis, Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at CROI 2017.
    Faculty: Joel E. Gallant MD, MPH, Charles B. Hicks MD
    Released: 4/27/2017
  • Contemporary Management of HIV: New Data From CROI 2017

    In this downloadable slideset, Charles B. Hicks, MD, and Program Director Joseph J. Eron, Jr., MD, review key new HIV data presented at the Seattle 2017 meeting.

    Topics include:
    -New data on currently available ART
    -Switch/simplification strategies for virologically suppressed patients
    -Investigational ARV agents
    -Treatment complications and comorbidities
    Date Posted: 4/26/2017
10 of 190 Shown
Show 10 More